Skip to content

Clinical study of acupuncture in the treatment of intractable insomnia based on cerebrointestinal axis theory

Clinical study of acupuncture in the treatment of intractable insomnia based on cerebrointestinal axis theory

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200064743
Enrollment
Unknown
Registered
2022-10-15
Start date
2022-10-15
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

insomnia

Interventions

observation group:Acupoints are taken according to the cerebral and intestinal axis
control group:conventional acupuncture

Sponsors

The third Affiliated Hospital of Henan University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Patients with stubborn insomnia who meet the diagnostic criteria of traditional Chinese medicine and Western medicine for insomnia; 2. Age range from 18 to 65 years old (including 18 and 65 years old), regardless of gender; 3. The course of the disease is>=6 months; 4. Pittsburgh Sleep Quality Index (PSQI) score>7 points; 5. Not receiving insomnia related treatment one week before treatment; 6. Able to independently fill out various rating scales; 7. Those who voluntarily participate in this experiment and sign an informed consent form; 8. Strictly follow the treatment methods specified in this study, obey the doctor's arrangements, and be able to consistently cooperate with treatment and follow-up.

Exclusion criteria

Exclusion criteria: 1. Women who are breastfeeding or pregnant; 2. It cannot be ruled out that insomnia patients are caused by organic diseases or mental disorders, as well as alcohol or drugs; 3. Patients who cannot withstand acupuncture stimulation, are prone to dizziness or allergies to needles.

Design outcomes

Primary

MeasureTime frame
Pinsburgh Sleep Quality Index,PSQI;

Secondary

MeasureTime frame
TCM symptom scale;ISI;HAMA;HAMD;Brain neurotransmitte;

Countries

China

Contacts

Public ContactGao Hongmin
sfysxk@126.com+86 17537128630

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026